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INTRODUCTION 
Lysozyme is a bacterolytic enzyme which is found in most animal 
tissues and secretions and whose substrate is the mucopolysaccharide 
of the bacterial cell wall. Because of its specificity and its dis¬ 
tribution, there is some evidence (27) that lysozyme plays an important 
role in the intracellular resistance to bacteria; however, the bacteri¬ 
cidal role of lysozyme in the body has not received good supporting 
evidence except for Micrococcus lysodeikitus (8) where inhibition of 
intracellular killing was effected by the use of the methyl ester of 
lysozyme, a competitive inhibitor. 
It was felt that better evidence concerning the role of lysozyme 
in resistance to infection could be obtained if a specific inhibitor 
of lysozyme were found, and, thus, an antibody to rat kidney lysozyme 
was prepared. Once the anti-lysozyme antibody was obtained, it was 
decided to study the distribution of lysozyme within phagocytic cells 
in preparation of attempts to inhibit the intracellular killing of 
bacteria. 
Even though the kidney is not a member of the reticuloendothelial 
system, a high concentration of lysozyme is found (81). In order to 
determine the function of this kidney lysozyme, it was decided to study 
the distribution of lysozyme within the kidney. 
All of these studies were carried out with antibody to rat kidney 
lysozyme and with rat and mouse tissues, using fluorescent antibody 
techniques. However, there were difficulties in obtaining enough material 
for the extraction procedure and in obtaining large quantities of rat 
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polymorphonuclear leucocytes. Because of these difficulties and because 
of the interest in human resistance to infection, it seemed fruitful to 
continue these studies with lysozyme from human kidney and with human 
tissues; therefore, it was necessary to establish an extraction procedure 
for lysozyme from human kidneys. 
Recently the separation of isoenzymes has become a diagnostic aid 
in clinical medicine. Since it has been shown by chromatographic proced¬ 
ures (124, 125) that there do exist isoenzymes of lysozyme, it seemed 
appropriate to try to electrophoretically separate the isoenzymes to 
see if this separation would be of any diagnostic aid. 
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THE HISTORY OF LYSOZYME 
Fleming's Work 
In 1922 Alexander Fleming reported (30) the discovery of a substance 
in nasal secretions from a patient with acute corzya which was able to 
lyse certain strains of bacteria. He called this substance, lysozyme. 
The substance was discovered because the patient's nasals secretions, 
when cultured, grew out only an occasional staphylococcus instead of the 
expected lush growth for the first three days while on the fourth day 
they grew out a bacterium which Fleming named Micrococcus lysodeikitus. 
This bacterium was extremely susceptable to lysis by lysozyme, and 
Fleming used this property to establish a test system for the presence 
of lysozyme (32). A well would be made in an agar plate and filled with 
agar in which the solution or tissue to be studied had been placed. 
The whole plate would then be covered by a layer of agar containing 
Mo lysodeikitus which would then grow up except in a zone around the 
test well where there would be lysis if lysozyme were present. The 
greatest dilution at which a zone of lysis was still present was taken 
as the titre of the lysozyme in the substance. With this method Fleming 
showed that human tears had the highest lysozyme concentration followed 
by nasal secretions and sputum. Florey (35) using the same method but 
a more complete list of sources, showed that the greatest titres were 
found in the kidney, stomach, and salivary glands followed by the spleen, 
lungs, liver, and cartiledge. 
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Although Fleming was primarily a bacterologist, he did a remarkable 
job in characterizing some of the physical properties of lysozyme (31). 
He showed that its size (molecular weight) was approximately equal to 
that of trypsin by agar diffusion studies. He also demonstrated that 
lytic activity increased with temperatures up to 60°C and that both acid 
and base inhibited the rate of the reaction. The optimal NaCl concen¬ 
tration for the lysis of M. lysodeikitus was 0.57. (33). Contrary to 
most enzymes the activity of lysozyme remained after boiling in acetic 
acid for five minutes. He also noted that either cotton or filter paper 
absorbed lysozyme. Fleming felt that lysozyme was neither an antibody 
nor an opsomin because it was not consumed during the course of the 
reaction. 
Ultimately Fleming and Allison noted that occasionally colonies 
grew in the inhibitory zones. These strains were lysozyme resistant. 
Since a strain that was resistant to a lysozyme from one source was 
resistant to the action of all lysozymes, Fleming at first felt that 
lysozyme from all sources was the same (34). In later papers, however, 
he adopted the view that lysozymes from different sources were not 
identical. 
Besides his work on the action of lysozyme on M. lysodeikitus, 
Fleming studied the effect of lysozyme on other bacteria: 75% of labora¬ 
tory bacteria were lysised by a 1/1000 dilution of tears, 7 of 8 strains 
pathogenic for animals but not for man, and 72% of intestinal streptococci 
but no strains of salmonella or pneumococcus. 
Other Contributors 
Other investigators during the 1910's and 1920's had done work on 
what was later realized to be lysozyme. Laschtschenko (61) and Rittger 
and Sperry (101) showed that egg white had a bactericidal effect that was 
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destroyed by heating. The spectrum of this bactericidal effect was 
the same as that described by Fleming for lysozyme from human tears. 
These investigators believed, however, that the bactericidal power 
was a function of egg white only. 
In 1921 Gengou (40) reported the presence of a bactericidal sub¬ 
stance in extracts from white blood cells which had many of the 
properties that Fleming had described for lysozyme. At the same time 
Turro (128) reported the existance of a bacterolytic substance in 
tissues. 
In one of his papers Fleming quoted Melchnikoff, "Nature does 
not make use of antiseptics to protect the skin and mucous membranes. 
The fluids which moisten the surface of the mouth and of other mucous 
membranes are not microbicidal". After Fleming had shown the mistruth 
of this statement in relation to M. lysodeikitus, other investigators 
began to study the effect of human secretions on more pathogenic 
bacteria. Ridley (98), using 907o tears, studied a variety of bacteria 
showing that at that concentration the tears inhibited many strains of 
staphylococcus, streptococcus (hemolytic and fecal), and pneumococcus. 
Whereas 90% tears did inhibit these bacteria, 75% did not. Ridley showed 
that in many conditions in which infections of the eye were common 
(phlyclinular conjunctivitis, interstitial keratitis, foreign body 
retention, and epiphora), the lysozyme content was only 50% of normal; 
at this concentration of lysozyme many bacteria which were usually 
inhibited were able to grow, and Ridley felt that the lowered lysozyme 
concentration was the cause of the increased infection rate. Fleming 
thought as a result of Ridley's work that one possible explanation of 
the presence of intracellular gonococci was that the white cells in which 
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the gonococci were found were different in lysozyme content since the 
gonococcus was readily destroyed in phagocytic experiments. 
Two other investigators, Rosenthal and Lieberman (104), were in¬ 
terested in the effect of the lysozyme in milk (both human and cow) on 
the intestinal flora of infants. Human milk has a much higher concen¬ 
tration of lysozyme than cow's milk probably due to the increased volume 
of the cow's production. When either boiled human or cow's milk was 
fed to infants having equal numbers of Gram negative and positive 
organisms, there was an increase in the Gram negative population whereas, 
if the infants were fed human milk, there was a decrease in the number 
of Gram negative organisms. 
Thus, before the advent of antibiotics, much of the knowledge 
concerning a bactericidal agent, lysozyme, had been discovered. However, 
with the emergence of other means of controlling infectious disease, 
interest in lysozyme as a drug diminished. Later it was replaced by 
interest in lysozyme as a microbiological research tool. 
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PHYSICAL PROPERTIES OF LYSOZYME 
So many substances have been discovered that can cause the lysis 
of M. lvsodeikitus that certain properties have to be possessed by a 
lytic enzyme in order for it to be called, lysozyme; it has to be a 
basic protein of low molecular weight which retains its activity after 
boiling in acetic acid for 1-2 minutes and whose lysis of a suspension 
of M. lvsodeikitus produces the appropriate degradation products (52). 
In order to give lysozyme a more exacting name it has also been called 
^-glucosaminidase, murmidase, N-acetylmuramide glycanohydrolase or 
E.C.3.2.1.17. These names all relate to the nature of its specific 
substrate. 
Lytic enzymes which fulfill these criteria are found in the tissues 
and secretions of most humans and in many other vertibrates and invert- 
ibrates. They also are found in plants (papaya latex)(117), associated 
with phage (T2)(57), and in bacteria (B. subtilis)(97). Most studies 
on lysozyme, however, have been done with egg white lysozyme. The 
molecular weight of all strains of lsyozyme studied have been in the 
range, 14,500 ^ 500 with the exception of papaya latex lysozyme whose 
ioolecular weight is 25,000. The molecular weight of egg white lysozyme 
from its amino acid analysis is 14,386. The shape of the native protein 
is probably an oblate ellipsoid with an axial ratio of 3:1 and with a 
hydration of 0.6 grams of water per gram of protein (21, 62, 122). 
The complete amino acid sequence of egg white lysozyme recently 
has been elucidated separately by both Jolles (55) and Canfield (11). 
(Figure 1) Lysozyme is the first protein which has been shown to contain 
all the amino acids. The large numbers of basic amino acids in the 
> . ■ i 
i , . .. .. . ■ r ■ ' J., . 1 
. 
. ... ' > - . ...i :: '• > .• _ < ' '. . : • ' ■ 
. ~ • 
. ,• ' ' 
.j . i , J oo >. •; < -'1 O n'£ 
■ . ' • “> > • ' I ' 1 ' ' ■ . , 
r ...... 
. ' 
;, . • is'!. ,j. 
j■■ ••• O' • 
.... • •:-. ■ < 
i-i ■ i , . ••••••. ' . to: . •« 
. 
V; ) , .• i £i . • .i r, , '•< • •. J ">• ..'J - (.• . •* . . . - 
- . 
> • ' . • - ' 
; . <• • . . . i ■ ' yJ-OH '■ - * ■ 
. ; . 
O' • > ■ '. O' ' • --i 
. ■ - ; . . ! • . ■ . • • - 
1 ■ ) 
T, ; . ' - . _/ • 
-8- 
molecule are responsible for its high isoelectric point, 10.5-11.0. 
There are four S-S bridges, the reduction of which produce only one 
peptide chain showing that the molecule is only a single chain. 
|HjLys-Val-Phe-Gly-Arg-Cys-Glu-Leu-Ala-Ala-Ala-Met-Lys-Arg-His-Gly-Leu-Asp 
Lys-Ala-Ala-Cys-Val-Try-Asp(NH2.)-Gly-Leu-Ser-Tyr-Gly-Arg-Tyr-Asp(NH2) 
1 I ‘ ' 
Phe-Glu-Ser-Asp(NH2)-Phe-Asp(NH2)-Glu(NH2)-Ala-Thr-Thr-Asp(NH2)-Arg 
Ileu-Asp(NH2)-Glu(NH2)-Lcu-Ileu-Gly-Ty r-Asp-(Thr,Ser,Gly,Asp(NH2),Thr)-Asp 
S 
Ser-Arg-Try-Try-(Cvs,Asp ,Asp(NH2) ,Gly)-Arg-Thr-Pro-Gly-Ser-Arg-Asp(NH2) - Leu 
Asp(NH2)-Ser-Ala-Thr-Ileu-Asp-Ser-Ser-Leu-Leu-Ala-Ser-Cys-Pro-Ileu-Asp(NH2)-Cysj 
I  i  l —1 |_ _S 
Val-Cys-Ala-Lys-Lys-Ileu-Val-Ser-Asp-Gly-Asp-Gly-Met-Asp(NH2)-Ala-Trv-Val-Ala 
S | | 
lieu-Try- Ala-Glu(NH2)-Val-Asp-Thr- Gly-Lys-Cys-Arg-Asp(NH2)- Arg-Trv 
[ S 
Arg-Gly-C^s-Arg-Leu-OH~| 
S 
Figure 1 
Amino Acid Sequence of Egg White Lysozyme 
The determination of the amino acid sequence of lysozymes from 
different sources is being attempted in order to discover if there 
are any areas of the sequence that are identical in the different 
lysozymes. These areas of agreement would probably be the active site 
and the combining site. However, thus far no areas of identity have 
been found. 
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ACTION OF LYSOZYME 
It was not until 1936 that attention was turned from the lysis 
of sensitive organsims to the elucidation of the characteristics of 
the substrate for the enzyme. In that year Meyer and his co-workers 
(73) showed that the substrate for lysozyme probably was a mucopeptide 
in the cell wall of the bacteria. Then Epstein and Chain (28) published 
their work in which they stated that the substrate for lysozyme was a 
high molecular weight polysaccharide which liberated N-acetylated 
aminodexoses upon degradation. They felt that in the susceptable 
bacteria the polysaccharide was found in a water insoluble form in the 
cell wall and that after reaction with lysozyme it became water soluble. 
The definitive work on the nature of the substrate for lysozyme 
has been done by Salton (105, 107, 108, 110, 113, 114). He has shown 
that the products of M. lysodeikitus cell wall digestion by lysozyme 
consist of two fractions, one dialysiable and one not dialysiable. The 
non-dialysiable fraction has a molecular weight of 10,000 to 20,000. The 
structure of the dialysiable fraction has been determined to be 6-0-^-N- 
acetylglucosaminyl-N-acetylmuramic acid and its dimer with a t (l-*4) 
bond. It seems, therefore, that the backbone of the mucopeptide molecule 
contains N-acetylglucosamine and N-acetylmuramic acid bound in pairs with 
lysozyme resistant 
bonds. To this backbone would then be coupled the various other components 
of the cell wall. 
The dialysiable fraction contains di- and tetra-saccharides. In view 
of the recent evidence that lysozyme can act as a condensing as well as 
a cleaving enzyme, the presence of dimers is not surprising. 
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NAG U NAMA U. NAG l-4 NAMA U NAG 1 % NAMA 
peptide peptide 
Figure II 
Polysaccharide of Bacterial Cell Wall 
All cells studied that are susceptable to lysozyme lysis at least 
three amino acids have been found: D-glutamic acid, alanine and either 
lysine or diaminopimelic acid (139). These amino acids are arranged in 
peptide chains that are joined to the muramic acid residues. The existance 
of large molecular weight, non-dialysiable digestion fragments is possibly 
due to crosslinkages between the peptide chains so that, although the 
lysozyme sensitive bonds would have been cleaved, the molecule would 
still be held together by the crosslinkages (112). 
The cell walls of lysozyme sensitive M. lysodeikitus is almost pure 
substrate for lysozyme and a good source for substrate for enzymatic 
studies. However, as Fleming first showed, there are strains of M. 
lysodeikitus that are resistant to the action of lysozyme. Brumfitt, 
Warlaw, and Park (9) have shown that in one resistant strain (L250) the 
resistance is associated with increased 0-acetyl content of the polysaccharide. 
If the acetyl groups are removed by hydrolysis, the susceptability of the 
organism to lysis is restored. However, not all lysozyme resistance 
can be correlated with increased 0-acetyl content(69). 
As Fleming and Ridley showed, there is a wide range of Gram positive 
organisms that are sensitive to lysozyme, including strains of staphylococcus, 
pneumococcus, hemolytic and fecal streptococcus, gonococcus, and salmonella. 
Most Gram positive organisms, however, are resistant (138). If the cell 
walls of lysozyme resistant bacteria are chemically altered, however, then 
they may become sensitive to the action of lysozyme; thus, the cell walls 
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from Group C streptococci become sensitive after trypsinization (60) and 
those from Group A streptococci after hot formamide extraction (59). 
Protoplasts can be formed from Group D streptococci by the action of 
lysozyme (7). 
Since Gram positive cell walls are primarily mucopeptide in nature, 
containing peptides, amino sugars, and sugar constituents, and, since the 
chemical constituents are the same for resistant and non-resistant 
organisms, except in exceptional cases, chemical differences do not seem 
to be the basis of resistance. It has been suggested that resistance 
may be due to difference in the bonds between the amino sugars, increased 
crosslinkages between the peptide chains, or decreased sugar content. All 
of these would decrease the amount of substrate readily available to the 
lysozyme and, thus, decrease the sensitivity of the cell wall to the action 
of lysozyme. (109). 
As a group Gram negative bacteria are less sensitive to lysozyme 
than Gram positive ones (83); however, some organisms like Brucella abortus 
are moderately lysed (106). In contrast to the relatively simple 
structure of the Gram positive cell wall, the walls of Gram negative 
bacteria are most complex, containing polysaccharides, a greater range 
of amino acids, and lipids. 
Treatment of Gram negative organisms may produce forms that are 
lysozyme sensitive. Pseudomonas aeruginosa after treatment with acetone 
becomes lysozyme sensitive (131). The treatment of Gram negative organisms 
with Versine (EDTA) can lead to lysozyme lysis in a tris buffer system (95). 
Incubation of Gram negative bacteria at low pH,/v'3.5, followed by sudden 
alkalization to a basic pH,’"'/10.0, will lead to lysis after lysozyme treat¬ 
ment. Ralston and Elberg (90,91) have shown that the addition of glycine 
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to the culture media of polymorphonuclear leucocytes will increase 
the intracellular killing of Brucella. Although it has not been 
definitely proven, it seems that all these treatments increase the 
availability of the substrate to the action of the enzyme. Acetone, 
heat and acid will destroy the outer layer of the cell wall while the 
glycine and EDTA will chelate inhibitory metal ions tnat are found 
in the cell wall. 
Another interesting experiment is that of Weidel who showed that 
the lytic enzyme of the phage, which is a lysozyme, can lysis the 
inner most cell wall layer of E. coli without any pretreatment (58, 133, 
134). This observation probably explains how spontaneous lysis of the 
infected bacteria takes place. Since the lysozyme is already within 
the cell and since the polysaccharide is the inner most layer, there 
is no need for adjuvants in order for the lysozyme to reach the substrate. 
It is possible that within the system of human bacterial defense 
mechanisms lysozyme is the final agent in the process of bacterial 
destruction (43). Whereas, when a bacterium is first injested by a 
member of the rectuloendothelial system, it may be resistant to the 
action of lysozyme; the action of the other enzymes within the cell 
(trypsin, acid and alkaline phosphatases) may alter the structure of 
the cell wall in such a manner that the wall is then lysozyme sensitive. 
Glynn and Brumfitt (8) have shown that in the case of Micrococcus 
lysodeikitus its intracellular destruction can be inhibited by the 
methyl ester of lysozyme, which is a specific competitive inhibitor 
of lysozyme; these experiments have increased the evidence for the role 
of lysozyme in the body's defense mechanisms. 
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ASSAY METHOD OF LYSOZYME 
History 
The first method for the determination of lysozyme content was 
that of Fleming in which the greatest dilution of a substance that 
caused the production of an area of lysis on an agar plate seeded with 
M. lysodeikitus was the titre of the lysozyme present. This original 
method as well as the other methods which evolved involved the lysis 
of suspensions of M» lysodeikitus had the limitation that they gave 
only qualitive lysozyme concentrations. 
The most quantative method that has been devised for lysozyme 
determinations is that of Litwack (63,86). In his test system to a 
standard suspension of M. lysodeikitus in standard buffer is added 
the solution to be tested, diluted with buffer if needed. The trans- 
missance of the solution is plotted against time, and then taking the 
rate of change the concentration is determined from a standard curve. 
There has been much disagreement as to the nature of the reaction 
between lysozyme and the cell walls of M, lysodeikitus. Various authors 
have reported the order of the reaction as 0~, 1 —, or 2— with respect 
to the enzyme. Litwack showed that in his system that a straight line 
is produced if 1/absorbence is plotted against time for the first four 
minutes of the reaction, and, thus, during this period the reaction is 
2~ order and that then the order becomes 0^ or 1— if the reaction is 
allowed to progress. 
In preliminary experiments it was shown that the plot of trans- 
missance vs time over the first two minutes of the reaction gave a 
straight line and that the plot of the slope of the reaction against 
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the concentration of the enzyme in the range, 0—10 ug/ml, gave a 
linear relationship. 
Me thod 
A test suspension of M. lysodeikitus, strain 
L2, 28 mgm%, is made up in a buffer that is 907» 
phosphate buffer, pH 6.5, 0.1 M and 10% 1% NaCl. 
Readings are taken on a Spekker (Helger and Watts, 
Ltd., London) with a H508 filter using a 2x5 cm, 
curved bottom cell. To 4.5 ml. of the test suspen¬ 
sion of the bacteria is added 0.5 ml of the unknown 
solution with vigorous pipetting. The transmissance 
of the solution with 5.0 ml of the test suspension 
as a blank is read and plotted at 15 second inter¬ 
vals for two minutes. The slope is determined, and 
the lysozyme content read from the standard curve. 
A standard curve has to be prepared for each day 
using crude Armour egg white lysozyme (Armour and Co., 
Chicago) as the reference material since the ambient 
temperature and the condition of the test suspension 
will alter the standard curve. 
Discussion 
The Micrococcus lysodeikitus is grown on large nutrient agar plates 
harvested, and freezed dried. When the test suspension is first made up 
it will have an OD of 60 which will decrease over the first 24 hours due 
to spontaneous lysis. Good results are obtained if the OD is between 50 
and 60; if it is any lower, the change is the transmissance will not be 
great enough to give good results. 
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Figure 3 shows the typical graph of transmissance against time; 
there is a sudden increase in transmissance with the addition of the 
unknown solution, followed by a period of steady change, and finally 
with high lysozyme concentration a slowing of the rate of change due 
to product inhibition of the reaction. 
Figure 4 shows a typical standard curve of the rate of change 
of the transmissance of the test bacterial suspension against the 
lysozyme concentration. The nature of the standard curve, which is 
linear at low lysozyme concentrations, changes depending upon the age 
of the bacterial suspension. A new suspension has a negative y inter¬ 
cept showing its relative resistance to lysis while an old suspension 
has a positive y intercept and a great slope showing is greated sus¬ 
ceptibility to lysis. 
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Lysozyme concentration in ng/ml 
Figure 4 
Rate of change of transmissance vs lysozyme concentration 
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PREPARATION OF HUMAN KIDNEY LYSOZYME 
History 
The richest readily available source of lysozyme is hen's egg 
white, and most of the original attempts to purify lysozyme delt with 
this source. Wolff in 1927 (137) attempted to remove inert protein 
from egg white,with colloidal iron and then to precipitate the lysozyme 
with acetone. This method was followed by a series of methods (3, 4, 
96, 102), the most commonly used of which was that of Meyer (72) in which 
the acetone precipitated proteins were extracted with acid-alcohol, 
followed by alcohol precipitation, isoelectric precipitation of active 
proteins by sulfuric acid, and then precipitation of the lysozyme by 
flavianic acid. 
The most recent of the precipitation methods is that of Perri in 
which the organ under study is homogenized with three volumes of M/15, 
pH 6.5, phosphate buffer, and then an equal amount of 1% acetic acid- 
alcohol added. The mixture is centrifuged, the supernatient mixed with 
six volumes of absolute alcohol, the precipitate saved, redissolved in 
water, and recrystallized from an alcohol-mixture. 
With the emergence of ion exchange column chromatography an easier 
way to purify the enzyme using a weakly acid resin, IRC-50, was shown. 
Reports followed of the isolation of lysozyme from rabbit spleen, dog 
kidney, dog spleen, rat kidney, and papaya latex. The first reported 
isolation of a lysozyme from a human source was that of Litwack (68) 
concerning the isolation of lysozyme from human kidneys; Jolles then 
followed with the report of the isolation from human milk (53). 
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When it was decided to prepare a pure lysozyme from a human 
source, the kidney was chosen because of its high lysozyme content 
and ready availability. In all reported methods for the isolation 
of lysozyme, the resin, IRC-50, was used. However, in preliminary 
attempts to reproduce the methods of Litwack, Jolles, and Perri, great 
difficulty was encountered in eluting the enzyme from the resin. 
Therefore, it was found necessary to devise a new extraction procedure. 
Method 
Post-mortum human kidneys are homogenized in 
three volumes of distilled water, and then three 
volumes of 5% acetic acid-alcohol are added. The 
mixture is stored in the cold, solid material is 
removed by centrifugation, the supernatient saved, 
and its pH adjusted to 5.5. The solution is run on 
to a column of carboxymethylcellulose (Whatman's CM 
70, London, England), 1x20 cm, which is prepared to 
the following specifications: phosphate buffer, 
0.01 M, pH 5.5. The column then is eluted with a 
pH-molar gradient. A 500 ml mixing chamber is 
filled with phosphate buffer, 0.01 M, pH 5.5, to 
which is attached a resevoir which contains phosphate 
buffer, 0.2 M, pH 7.5, so that a constant volume is 
maintained in the mixing chamber. 
Ten milliliter samples are collected with a flow rate of 60 ml/hr. 
Protein concentrations are determined by absorbency at 280 mu, and 
lysozyme concentration determined in the usual manner. All tubes with 
activity greater than 10 ug EEWL/ml are pooled, acidified to pH 5.5, 
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and dialysed against distilled water for one hour. The solution 
then is run on to a second CMC column prepared as the first and again 
eluted with the same pH-molar gradiant. All tubes with activity 
greater than 10 ug EEWL/ml are pooled, dialysed against distilled 
water for three hours, and freezed dried. 
Results 
Other authors have noted that during the purification of human 
kidney lysozyme a 25% increase in activity was noted which lead to 
the hypothesis that an inhibitor of lysozyme may be naturally present. 
During the purification procedure which has been outlined above, an 
even more marked increase in activity is noted. 
Table I 
Total lysozyme activity during purification 
Total lysozyme 
in mg equivalent EWL 
Filtered supernatient 30 
After 1st elution from CMC 44 
After 1 hour dialysis 35 
After 2nd elution from CMC 95 
After 3 hour dialysis and freeze drying 67 
The first elution produces a 50% increase in activity which is 
of the same magnitude as has previously been reported. However, the 
second elution produces a 200% increase in activity. The actual 
increase may be higher since there are absolute losses which can better 
be seen when small amounts are used. It is probable that there is 
a substance in kidney which is inhibitory for lysozyme, either specif¬ 
ically or non-specifically, and which is removed by the purification 
procedure. 
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Since lysozyme has such a high isoelectric point, it was reasonable 
to assume that the inhibitor had a lower isoeletric point and, therefore, 
either would not be absorbed on to the CMC at all or would be eluted 
before the lysozyme. Attempts to discover the location of the inhibitor 
by mixing various elution samples with purified lysozyme produced no 
inhibition. At this point an observation helped to clarify the situation. 
In one preparation of human kidney lysozyme there was no activity in the 
filtered supernatient before it was run through the CMC column. If the 
activity was measured after it had been run through the CMC column, there 
was lysozyme activity present. This observation was surprising in that 
the column was obviously overloaded, and the theory that the inhibitor 
was more acidic than lysozyme would mean that the lysozyme would be more 
readily bound than the inhibitor; the converse, however, seemed to be 
true, that the inhibitor was more readily bound than the lysozyme and, 
therefore, must be more basic. Since lysozyme has an isoelectric point 
of 10.5, there are not many naturally occuring compounds that have a 
higher isoelectric point. 
One physologically occuring compound which fulfills some of these 
properties is spermine (48, 123), a biological polyamine which is found 
throughout the body. Hirsh and Dubos studied its effect on the tubercle 
bacilli, especially its ability to inhibit growth. During the extraction 
of spermine they noted that lysozyme activity was present at all stages 
of the procedure and could finally be removed by dialysis although 
spermine's molecular weight is 203 and lysozyme's is 14,500. They were 
interested in obtaining pure preparations of spermine, not lysozyme, and 
therefore, it is impossible to know if the spermine had any inhibitory 
effect on the lysozyme. However, spermine is a basic compound with the 
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same distribution as lysozyme that is extracted with lysozyme; these 
are all characteristic of the postulated inhibitor. 
Discussion 
Post-mortum kidneys are obtained from persons who have not had 
clinical evidence of renal disease and kept frozen until used, 1 to 6 
months. It seems that more lysozyme is extractable from the kidneys 
which have been frozen for the longest length of time although it has 
not been proven. 
In the above method distilled water is used instead of 15/M 
phosphate buffer is order to keep the salt concentration as low as 
possible to facilitate the adsorption on to the CMC. The 507o alcohol- 
water precipitates most of the larger molecular weight proteins while 
the acidification of the solution makes the lysozyme more stable. 
Some difficulty was encountered due to shrinkage of the column because 
of the high alcohol content of the mixture, and for this reason CM-Sephadex 
which was first used was discarded in favor of CMC. 
The adjustment of the pH of the supernatient to 5.5 causes a 
precipitate to form which clogs the CMC column if used immediately. 
Therefore, the adjusted supernatient is allowed to stand overnight and 
filter through filter paper. According to the studies of Fleming this 
filtration will lead to the loss of some lysozyme, but this source of 
loss was not studied. 
In some preparations a peak appears between the first elution peak 
and the lysozyme peak which is pink in color and is probably the heme 
group of cytochrome c, liberated by the acid-alcohol, with an absorbance 
peak at 428 mu. 
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The gravest difficulty that is encountered is the problem of 
desalting. It is necessary to reduce the salt concentration of the 
elutent from the first column before it is run on to the second column. 
Also it is necessary to desalt the final sample as much as possible 
before freeze drying in order to minimize protein inactivation. Usually 
to desalt protein solutions, visking dialysis tubing is used. However, 
due to is peculiar properties, lysozyme has the ability to diffuse through 
regular dialysis tubing. If the data of Leonis is correct and lysozyme 
has an axial ratio of 5:1, then the cross-sectional area of the molecule 
might be small enough to pass through the pores of the tubing. There 
are several methods reported to decrease the permeability of dialysis 
tubing including baking, stretching, and acetylation. Usually 24/32" 
tubing was used although according to Craig the 18/32" diameter tubing 
is the least porous, but there is no explanation of this difference (25). 
Tubing that is heated at 90°C for 4 hours is decreased 10% in length 
and becomes colored with a brown material that is removed by washing; 
however, the rate of loss of lysozyme from the heated tubing is not 
reduced as compared to controls. Craig also has shown that permeability 
can be decreased by the longitudinal stretching of the dialysis tubing. 
Craig thinks the stretching changes the spacial configuration of the 
pores. By using a rack the length of the tubing could be increased 20% 
and held overnight in the stretched form. When tubing thus prepared is 
tested with lysozyme dissolved in water with unstretched tubing as a 
control, the overnight loss is only 25% of the control tubing; however, 
if the lysozyme is dissolved in M/15 phosphate buffer, there is no differ¬ 
ence in the rate of loss. Thus, the presence of salt during the dialysis 
produces such a force on the lysozyme that there is no difference in the 
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rates of diffusion. Attempts at acetylation of the tubing with acetic 
anhydride in pyridine did not produce a tubing with diffusion properties 
for lysozyme significantly different from the controls. 
Another method of desalting is the use of Sephadex of an appropriate 
size to exchange buffer for distilled water (84). Sephadex, however, is 
not completely inert so that in low salt concentrations because of its 
weakly acidic charge basic proteins like lysozyme stick to the column 
(41). Thus, when attempts are made to remove the salt, the lysozyme 
sticks and is lost. A further possibility is to exchange the phosphate 
buffer for a volatile buffer (54), such as pyridine acetate, which can 
be removed during the freeze drying process. Attempts at exchanging 
buffers were a success; however, since it takes 14 grams of Sephadex 
to completely exchange 10 ml of solution, it is an impractical method 
when liters have to be desalted. 
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RABBIT ANTI-KIDNEY LYSOZYME 
History 
The first reported preparation of an anti-serum to lysozyme was 
that of Jermoljewa and Bujanowskajo (49) who in 1931 prepared anti¬ 
serum to amorphous egg white lysozyme, thus, showing that lysozyme was 
antigenic. In 1937 Roberts reported that anti-serum to egg white 
lysozyme did not react with lysozyme from human or cat saliva. These 
results were the first direct evidence that there was more than one 
lysozyme (103). 
The first preparation of an anti-serum to crystallized lysozyme 
was in 1947 by Smolens and Chainy (119). They showed that the lytic 
activity in their anti-serum was due to rabbit lysozyme that was not 
inhibited by the anti-egg white lysozyme. The rabbit lysozyme could 
be removed from the anti-serum by bentonite absorption. The best work 
on the nature of the antibodies to lysozyme is a series of papers by 
Shinho, Fujio et al. (38, 39, 115). They showed that in their anti¬ 
serum to EWL there were two specific neutralizing antibodies, one 
directed against the combining site and one against the active site. 
Immunization schedule 
For the primary injections 10 mg of protein is emulsified in 4 ml 
of complete Freund's adjuvant and is injected intramuscularly into each 
limb of an adult rabbit. After one month the animal is boosted with 
alum precipitated antigen, 4 mg, that is prepared by precipitating an 
aluminum potassium phosphate-protein solution with NaOH (74). This 
precipitate is washed with saline and injected in four intramuscular 
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sites in a 1:1:2 ratio on three alternate days. Bleeding is carried 
out via the marginal ear vein. The blood is allowed to clot, refrigerated, 
spun, and the serum is removed, absorbed with bentonite, filtered, and 
stored at 4°C. 
Cross reactivity 
The first studies on cross reactivity of different lysozymes and 
their derivitives were carried out using horse anti-egg white lysozyme 
kindly donated by Professor R. R. Porter. These studies were done 
utilizing the double diffusion technique of Ouchterlony (76,77). Attempts 
to use commercial agar for the gel met with little success since the 
lysozyme tended to bind to the agar and not to diffuse; thus, acrylamide 
was used as the gel base in barbitone buffer, pH 8.6, 1=0.07. The gel 
is poured into Petri dishes to a depth of 1 cm. Since the acrylamide 
will not gel in the presence of O2, the Petri dishes are placed in 
anerobic jars, evacuated, filled with hydrogen, and allowed to gel. 
This method produces good results, and the dishes are placed in the 
refrigerator until used. A hexangonal pattern with 1 cm wells and 2.5 
cm centers is used for the studies. 
The solution of antigen and antibody are diluted with buffer so 
that the precipitate line are midway between the wells. Studies were 
carried out with egg white lysozyme (EWL), methylated egg white lysozyme 
(ML), rat kidney lysozyme (RKL), rat spleen lysozyme (RSL), mouse kidney 
lysozyme (MKL), mouse spleen lysozyme (MSL), rat polymorph lysozyme (RPL), 
and mouse polymorph lysozyme (MPL). When horse anti-egg white lysozyme 
was used, there was cross reactivity between EWL and ML with spur formation 
but no reactivity with RKL, MKL, RSL, or MSL (Figure 6). 
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Figure 6 
Gel diffusion of anti-EWL and various lysozymes 
Figure 7 
Gel diffusion of anti-RKL and various lysozymes 
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An anti-serum was prepared to rat kidney lysozyme purified by the 
method of Perri (80). With this anti-serum there was cross-reactivity 
between the lysozymes from rat and mouse sources but no reaction with 
lysozyme from egg white. There was an inconsistant double line against 
rat spleen and polymorph lysozyme but only one line against rat kidney 
lysozyme and lysozyme from all mouse sources (Figure 7). 
The cause of the double line against RSL and RPL could not be 
determined. Since on immunoelectrophoresis the two lines move together 
and since they have come through a complicated purification procedure 
together, the double line is due to either a variant of lysozyme (either 
isoenzymes, dimer or denatured enzyme) or a closely related substance 
whose nature is unknown. 
These experiments show that antigenically several distinct forms 
of lysozyme exist with the antigenic differences becoming less as the 
phyllogenetic differences become less. It has been shown by other 
authors that lysozymes from closely related species have antigenically 
similar lysozymes. 
ft*-globulin preparation 
In fluorescent antibody work it is possible to work with whole 
serum, but the best results are obtainable if the ^-globulin fraction 
of the serum is used. The classical method of ^’-globulin preparation 
is the use of its insolubility in high salt concentrations (56). 
Anhydrous NaSO^ is added to the serum to make 
an 18% solution, and the precipitate is removed by 
centrifugation and then redissolved in water. This 
protein solution is then made up to 12% with respect 
to NaSO^, and the precipitate is collected and dis¬ 
solved. The ^-globulin is again precipitated by 
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127» NaSO^, redissolved, dialysed against buffered 
saline, and freezed dried. 
The yield of this method is 10 mg/ml of ^-globulin from normal rabbit 
serum. On electrophoresis a small amount of albumin contaminate is 
seen but no globulins other than gamma (Plate 1). 
Another method of purification of -globulin from whole rabbit 
serum has been developed from the fact that ^-globulins are the most 
basic of the serum proteins (120, 121). 
A DEAE-Sephadex column is prepared and equi- 
liberated against phosphate buffer, pH 6.4, 0.0175 M. 
Usually one gram of DEAE-Sephadex is used for 3 ml of 
serum. The serum is dialysed against the buffer over¬ 
night, run on to the column, and eluted with the same 
buffer. The ^-globulin is eluted as soon as the 
hold-up volume comes through, and all other serum 
proteins are bound to the column. All samples with 
O.D.s above 0.50 are collected and pressure dialysed 
to a suitable concentration. 
The yield of Y-globulin by this method is 4 mg/ml which is 
electropboretically pure. 
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Electrophoresis in 5% acrylamide, barbjLtone buffer, 
I = .07, 18 hours 
Top: Fluorescein labelled ^-globulin 
Middle: 'vhole rabbit serum 
Bottom: NaSO^ precipitated -globulin 
pH 8.5, 
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FLUORESCENT LABELLED ANTIBODY 
Introduction 
Once the specific nature of the antigen-antibody reaction was 
known, it was logical that this specificity would be used to establish 
the location of antigens. The most successful method using this 
specificity is that of the fluorescent labelled antibody. In 1942 
Coons showed that an antibody molecule could be conjugated with a 
fluorochrome with little loss of either activity or specificity; the 
titre of the labelled serum is 30% less than the whole serum. 
The three principal fluorochromes that are used are fluorescein 
isothiocynate (FITC), Lissamine Rhodamine B (RB 200), and 1-dimet’nyl- 
aminophthalene-5-sulfonic acid (DANS). The work in these studies was 
done with the first two of these. Aminofluorescein is a derivative 
of 4-nitrophthalic acid and resorcenol which absorbs maximally at 
495 mu and emits at 515 mu (85). Originally the isocynate was used 
for conjugation but more recently the isothiocynate has been shown 
to be more usable since it does not hydrolyse as readily (99,100). The 
emission peak of FITC labelled proteins used in fluorescent microscopy 
is the one at 520 mu which is excited by light at 325 mu. Lissamine 
Rhodamine B absorbs maximally at 570 mu emits at 595 mu. The sulphonyl 
chloride is used for the conjugation procedure, and the conjugated 
proteins used in fluorescent microscopy absorb at 435 mu and 350 mu 
and emit at 595 mu (yellow) and 710 mu (red) respectively. Thus, the 
shorter the wavelength of the exciting light, the higher the wavelength 
of the emitted light, or more red. Since both emission peaks are 
usually excited, the resultant color is orangiest. RB 200 is especially 
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useful when the tissue under study has a high yellow or green auto- 
fluorescence which would make contrast with fluorescence difficult. 
Method 
(1) The classical method of labelling proteins with FITC is that 
of Coons (24) with modifications. 
The method is as follows: 
The f -globulin solution is made up to a concen¬ 
tration of 5 mg/ml using Na2C0^-NaHCO^ buffer, pH 9.0, 
0.5 M. The amount of FITC is calculated on the basis 
of 3-4 mg FITC/gm ^-globulin; the crystalline form of 
the fluorochrome with twice the activity of the amor¬ 
phous form is used. The FITC is made up in cold dry 
acetone, 1 mg/ml. The protein solution is placed in 
a cold room in a flask with a magnetic stirrer, and 
the FITC added dropwise over a 15 minute period. The 
mixture is allowed to react overnight with constant 
stirring and with care that the pH is kept constant 
by the addition of buffer. 
The reaction mixture is then run through a G-50 
Sephadex column that has been equilibrated with 
buffered saline. The fluorescent labelled protein 
comes off as a rapidly moving band while the unre¬ 
acted fluorescein is a slower moving band. Sephadex 
removes the unreacted fluorochrome and exchanges 
buffers. If needed, the solution can be concen¬ 
trated by pressure dialysis. 
The ratio of fluorochrome molecules to protein molecules (F/P ratio) 
of fluorescein labelled protein prepared by this method is 1:75:1. 
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(2) Another method of preparing fluorescein labelled protein takes 
a much shorter time, 30 minutes (94). Celite is a silicous earth on 
which chemicals can be absorbed. A commercial preparation (Calbiochem, 
Los Angeles) is available that is 107,, FITC by weight. If this preparation 
is mixed with a protein solution, the rate of reaction is more rapid 
than when both reactants are in solution. The reaction has gone to 
completion within one minute of the Celite and the protein solution mixing. 
The method is as follows: 
The ^-globulin solution is made up to a concen¬ 
tration of 10 mg/ml with Na2C0^-NaHCO^ buffer, pH 9.0, 
0.5 M. The amount of 10% FITC added is calculated on 
the basis of 2 mg FITC/gm protein. The Celite-FITC com¬ 
plex is added to the protein solution in a test tube and 
shaken vigorously for three minutes. The Celite is re¬ 
moved by centrifugation, and the supernatient is placed 
on a G-50 Sephadex column and eluted with buffered saline. 
The F/P ratio of fluorescent antibody prepared by this method is 
3:3:1. 
(3) Although the F/P ratio of the fluorescent antibody labelled 
by the Celite method is quite good, the distribution curve of the F/P 
ratios is very broad. This means that many antibody molecules are 
overlabelled or underlabelled as compared to the average ratio. A 
new method of labelling procedures a population of fluorescent antibody 
molecules which are much more homogenous in their F/P ratio and which 
have a high F/P ratio(13). 
The method is as follows: 
The protein is made up to 10 mg/ml with Na2C03“NaHC03 
buffer, 0.025 M, and placed in 8/32" dialysis tubing. 
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This protein solution is dialysed against at least 
10 volumes of the same buffer with 15 mg% of FITC 
added at 4°C with continuous stirring. The extent 
of the labelling is dependent upon how long the 
reaction is allowed to run. 
Because the FITC solution is weak and the rate of the reaction is 
slow, the degree of labelling is very uniform. The amount of non¬ 
specific staining is very low even with high F/P ratios, 5— 10:1. 
The unreacted FITC is removed from the labelled protein by elution from 
a G-50 Sephadex column with buffered saline. If the reaction is allowed 
to run for 64 hours, the F/P ratio is 5.8:1 while a run of 96 hours 
will produce a ratio of 10.5:1. 
(4) RB 200 labelled antibody is prepared by means of the Celite 
method using Celite with 57„ RB 200. The amount of RB 200 to be used 
is calculated on the basis of 50 mg/gm y-globulin. The procedure used 
is the same as in the Celite-FITC method. The F/P ratio of this method 
is 2.5:1. 
Protein Determination 
The easiest method of protein concentration determination is the 
spectrophotoraetric reading of a protein solution at 280 mu (6) which is 
the absorbence peak for tyrosine. For ^"globulin the conversion factor 
is 1.4 O.D. units/mg/ml protein. However, this method is not usable for 
the determination of lysozyme concentrations or for the determination of 
the protein concentrations of fluorescent antibody solutions. Spectro- 
photometric methods (127, 130) for the determination of lysozyme protein 
concentration fail because of the high tryptophan content in lysozyme. 
Several methods are reported to avoid this difficulty, but all attempts 
to obtain constant conversion factors have failed. Because of the strong 
< ; - 
; . . . . 
•. < ... .. 
o.-J r-.fi 
. 
< 
o', i 
i ; 
. 
1 > i . , . . . •_ . ’ . >o> < • .■ 
■ . - 
-33- 
absorbency of the fluorochromes in the region below 300 mu attempts 
to quantitate the fluorescent protein solution by means of spectro- 
photometric methods were inaccurate. 
The method that was adopted was that of Folin-Lowry (70) in 
which the protein concentration is expressed in terms of a reference 
curve of bovine serum albumin. Both Folin phenol reagent and CuSO^-Na 
tartrate are used as reagents. The Folin phenol reagent reacts with 
aromatic amino acids while the CuSO^-Na tartrate reacts with the 
peptide bonds giving an intrinsic double measurement. 
The procedure is as follows: 
Equal parts of 1% CuSO^ and 27» Na tartrate are diluted 
1:50 in 2% Na2C03 in 0.1 N NaOH. 0.5 ml of the protein 
solution is added to 2 ml. of the test reagent, shaken 
vigorously, and allowed to sit for 10 minutes. After 
0.2 ml of Folin reagent is added with vigorous shaking, 
the solution is allowed to sit for 30 minutes. Readings 
taken at 750 mu and 550 mu then are used to determine 
protein concentration from the standard curve for BSA. 
The amount of protein detected by this method is 10 — 100 ug/ml, 
far less than is needed for a Biuret determination. The lysozyme values 
obtained by this method are very constant, and the fluorochromes exert 
no interfering effect. 
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FLUORESCENT ANTIBODY STAINING 
Direct Technique 
Introduction 
The Coons fluorochrome antibody labelling technique has been 
refined, but the basic principals have remained the same (23). The 
gamma globulin from a specifically immune serum is isolated and 
conjugated with a fluorochrome. The labelled antibody then is applied 
to the section or smear under study and allowed to react. The un¬ 
attached antibody is removed by washing, and the slide then is viewed 
by means of ultraviolet light microscopy. The areas of specific 
fluoroescence represent the sites of localization of the antigen- 
antibody complex. 
Me thod 
After preparation of the fluorescent antibody it is 
stored at 4°C. If a large amount of anti-serum has been 
prepared, it is best to divide it into small vials and 
store at -20°C. When the anti-serum is needed, it is 
brought to room temperature and adsorbed with pig liver 
powder (lOOmg/ml) that has been moistened with buffered 
saline, pH 7.1, to reduce losses. The anti-serum should 
be adsorbed twice, including once overnight in the cold. 
The liver powder is removed by high speed (30,000 rpm) 
centrifugation for 45 minutes. The centrifugation also 
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removes denatured proteins which are produces during 
the freezing and thawing which, therefore, should be 
kept at a minimum. 
The fluorescent antibody is applied to cover the 
specimen that has previously been bathed in buffered 
saline to produce favorable conditions for the anti¬ 
gen-antibody reaction. The slides are placed in a 
moist chamber at 37°C for 30-45 minutes if the protein 
concentration of the fluorescent antibody is 3-5 mg/ml. 
If the concentration is less, 1 mg/ml, then 1-1% hours 
may be necessary. The slides then are washed for 30 
minutes with at least three changes of buffered saline. 
Prolongation of the washing time greatly enhances 
histologic definition. The sections are allowed to 
dry and then are mounted in 507o glycerol-507. buffered 
saline. The usual 907o glycerol is not used as a 
mounting medium because of its inherently high degree 
of non-specific fluorescence. 
Discussion 
The controls that are necessary with the direct staining technique 
are primarily two. The slides are pre-incubated with either unconjugated 
immune ^-globulin or normal ^-globulin. There should be a diminution 
or abolition of the specific staining on the slide that was incubated 
with the immune ^-globulin since it "blocks" by combining with the 
antigenic sites. There should be no change in the specific staining 
of the slide that was pre-incubated with the normal '-globulin. If 
there is any diminution, it is due to non-specific protein adsorption 
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rather than the blockage of specific antigenic sites. If a corresponding 
fluorescent antibody is available against an antigen not under study, 
the slide should be stained with it. There should be no staining since 
any staining will be due to the non-specific attachment of the fluorescent 
labelled protein. 
The chief advantage of the direct technique, thus named because 
the fluorochrome is directly attached to the specific immune antibody, 
is that the staining for more than one antigen is possible if the different 
antibody molecules are labelled with different fluorochromes. For 
instance, it would be possible to stain for the presence of bacteria 
within phagocytic vacuole while staining for the vacuole also. The 
fluorochromes can be chosen so that they can be visualized with the 
same incident light or under different conditions. 
The chief difficulty of the direct technique is that the number 
of fluorochrome molecules that are attached to the antigen under study 
is about one-third of that possible with the indirect technique; there¬ 
fore, the specific staining is fainter. Complete abolition of staining 
in the "blocking" control is almost impossible since it requires only 
a few non-blocked antigenic sites to produce some staining; thus, 
producing a diminution of specific staining rather than abolition. 
Indirect Technique 
Introduction 
In 1945 Coombs published (22) his work that is the basis of the 
indirect fluorescent antibody technique. The process is a two step one: 
the immune ^-globulin is used in an unconjugated form, and, after it has 
reacted with the antigen, a fluorescent antibody whose specificity is 
against the globulin of the animal species from which the immune globulin 
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was obtained is applied and allowed to react. Thus, the fluorochrome 
is attached to the antigen through two separate antigen-antibody com¬ 
plexes. Usually since the immune globulin is obtained from rabbits, 
the fluorescent labelled globulin is sheep anti-rabbit globulin which 
is commercially available. 
Method 
The fluorescent labelled anti-rabbit globulin, 
immune ^-globulin, and normal -globulin are 
adsorbed twice with pig liver powder (100 mg/ml), 
once overnight in the cold, before the first use 
and once before subsequent use. The liver powder 
and denatured protein are removed by high speed 
(30,000 rpm) centrifugation for 45 minutes. The 
immune globulin, 3-5 mg/ml, is applied to the section 
or smear that has previously been equilibrated with 
buffered saline and allowed to react in a moist 
chamber at 37°C for 45 minutes. The slides then 
are washed for 15-30 minutes in 2-3 changes of 
buffered saline. The slides are allowed to dry to 
keep from diluting the fluorescent labelled anti¬ 
rabbit globulin which is then applied. The slides 
are incubated in a moist chamber at 37°C for 45 
minutes, washed for 30-60 minutes with 3-4 changes 
of buffered saline, allowed to dry, mounted in 50% 
glycerol-50% buffered saline, and viewed under 
ultraviolet light microscopy. 
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Discussion 
The controls that are used with the indirect method are the use of 
normal Y-globulin or buffered saline instead of the immune Y -globulin. 
Both of these controls should be negative. To whatever degree the 
normal ' -globulin is positive is the degree of "non-specific" staining 
that is due to adsorption of the rabbit globulin onto the specimen. 
The degree of positive staining on the slide stained with(only fluorescent 
antibody is the "non-specific" staining due to non-specific reactions of 
the fluorescent labelled protein. 
The principal advantage of the indirect method is the increase in 
specific fluorescence that is possible. However many antigenic sites 
there are on the rabbit -globulin molecule, it is by that factor that 
the number of fluorochrome molecules is greater in the indirect as com¬ 
pared to the direct method. Also the controls present a much more "all 
or none" picture than the direct control slides. The chief liability 
of this method is that, except with great difficulty, it is impossible 
to stain for more than one antigen at a time. 
Non-specific Staining 
The chief difficulty in fluorescent antibody staining is the non¬ 
specific adherence of protein molecules to the tissue under study. The 
reason for this adsorption is that the protein molecules are charged, 
and, if the charge difference between the globulin molecule and the 
components of the specimen is great enough, then the strong forces of 
attraction will prevent antibody removed through washing. The more an 
antibody molecule becomes conjugated (the greater its F/P ratio), the 
more positively charged it becomes (36), and the more likely it will be 
non-specifically adsorbed. Thus, if the electrophoresis of normal 
^-globulin is compared to fluorescent labelled -globulin, (Plate 1) 
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it is seen that the fluorescent labelled globulin migrates further 
because of its greater positivity (26). 
Goldstein (45) has shown that samples with low F/P ratios, 2-3.5, 
give high specific staining and low non-specific staining while samples 
with high F/P ratios, 5-10, give high non-specific staining. It can 
thus be seen how the adsorption of the fluorescent antibody solution 
with pig liver powder decreases non-specific staining; the highly charged 
molecules are allowed to react non-specifically with the tissue powder and, 
thus, decrease the ultimate non-specific staining of the tissues under 
study. The best tissue powder to use, if a soluble antigen is under 
study, is a powder made from the tissue under study. If the antigen is 
not soluble, the powder of an organ from the same species that does not 
contain the antigen is best. If neither of these tissue powders is 
available, then pig liver powder can be used. The organ is homogenized 
and then washed with saline until all the blood is removed. The powder 
then is washed with acetone until all the color is removed. After drying 
the powder is ready for use. 
Goldstein claims that the best way to eliminate non-specific staining 
is to fractionate the fluorescent antibody on DEAE and to use only those 
fractions that have a suitable F/P ratio, 2-3.5. Cebra (12) has taken 
this method one step further by pointing out that, although antibodies 
with high F/P ratios are undesirable, molecules with very low F/P ratios 
are equally undesirable. Since they are poorly conjugated, they effectively 
block antigenic sites without producing fluorescence. Cebra feels that 
in Goldstein's method it is not recognized that there is a variation in 
the charge of normal ‘^-globulin. Thus, in one of Goldstein's fractions 
with a good F/P ratio, there will be some relatively positively charged 
3^-globulin with a low F/P ratio and some relatively negatively charged 
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-globulin with a high F/P ratio. Both of these would produce a 
fluorescent labelled antibody with the same charge and a solution 
with an acceptable F/P ratio. 
Cebra belives that the Y'-globulin first should be fractionated 
into several samples by using stepwise elution from DEAE with a weak 
phosphate buffer and increasing ionic strength, thus, producing samples 
of increasing acidity. Each sample then would be conjugated separately 
and separated on DEAE into samples whose F/P ratios would be determined. 
Thus, instead of two variables, the degree of conjugation plus the charge 
of the original ^-globulin, there would be only one variable, the degree 
of conjugation. Cebra has obtained good specific staining with little 
non-specific staining with fluorescent protein solutions as low as 200 
ug/ml. These separation methods can be used for the fluorescent anti¬ 
body in either the direct or indirect methods. 
Microscopy 
For all the fluorescent antibody work a Reichert microscope, 
"Zetopan" model, with an Osram HBO 200 mercury vapor lamp, was used. 
For brightfield viewing a BG 12/6 mm excitation filter was used which 
transmits 45% of the light at its maximum of 420 mu and has an excitation 
range of 350-475 mu. The cuf-off filters used for brightfield viewing 
were GG 9/1 mm and OG 1/1.5 mm. These filters were yellow in color and 
were acceptable with fluorescein whose emmission is at 495 mu; however, 
they did distort the normal blue auto-fluorescense of the tissues 
producing a green auto-fluorescence. 
This filter system was found to be unacceptable for the RB 200 
labelled antibody. Whereas usually RB 200 emits primarily at 715 mu 
and secondarily at 595 mu, in these experiments maximal fluorescence 
J ■- 1. V _ ■ 
' i 
■■■ c • ..;.;. • 
o .< • . . 
■ • i r. i' <. . . ii'. 
u i - • i 
< . • 
• ■ • . . ■ . . : . ) 
•' ’ • . - . •.> . ■ i : 
io '} I .'. <>n.l .1 i.d h j vbo4 
. < .• 
.. 
. . . : 
1 i. . 1- l i 
... i. t ■ -l < • I. _J 
. - J ( 
. ■’ ■ • - 
< • :v ii ; 
-41- 
was obtained at 595 mu which necessitated the use of darkground micro¬ 
scopy to that sufficient incident UV light could be used to stimulate 
the 595 mu emission of the RB 200. An UG 1/1.5 mm excitation filter 
was used which because of its thinness transmits 807, at its maximum 
of 360 mu, and a colorless GG 13/3 mm, Wartin 2 B, was used as the 
cut-off filter which allowed blue auto-fluorescence. The 715 mu emission 
of RB 200 was distinguished by using a darkground setup with a BG 12/2 
mm excitation filter and a GG 9/1 mm cut-off filter. It was shown that 
the red and white fluorescence coincided although there was greater 
definition with the white fluorescence. 
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MACROPHAGES AND POLYMORPHONUCLEAR LEUCOCYTES 
Experimental 
Peritoneal exudate macrophages were produced by the injection of 
5 ml of 1% glycerin intraperitoneally four days prior to the date of 
harvest. The peritoneum of the animal was washed out with Hank's solution 
to which 10% inactivated calf serum and 100 units/ml of heparin had 
been added. The usual yield per rat was 2 x 10^ cells of which greater 
than 907. were macrophages on stained smear. The cell suspension was 
placed in plastic wells, 1x2 cm, on chemically cleaned slides, the 
slides were placed in a moist chamber, and the cells were allowed to 
settle onto the slides. The wells were then removed, the slides washed 
in buffered saline, and the cells were flashed dried with a jet of CO2 
and fixed in cold absolute methenol. 
In some animals the trauma of the harvesting of the cells would 
injure the gastrointestinal tract, thus contaminate the macrophage 
suspension with bacteria. In other experiments dead bacteria were in¬ 
jected intraperitoneally prior to the harvesting of the cells. 
Polymorphonuclear leucocytes were prepared in one of two ways. They 
were obtained from either the blood of rats or mice or acute peritoneal 
exudates from the same animals. Blood could be collected from the plureal 
space of an animal after opening the chest wall and cutting the pulmonary 
artery. The blood was collected in heparinized pipettes, then was placed 
in plastic wells on clean slides, and was treated as the macrophage 
suspension is. Polymorphonuclear leucocytes could also be obtained by the 
production of an acute peritoneal exudate. Five milliliters of nutrient 
broth is injected intraperitoneally 2-4 hours prior to harvest. The cells 
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are harvested in Hank's solution with 107, inactivated calf's serum and 
100 units/ml of heparin added and fixed as before. The cells obtained 
were up to 50% polymorphonuclear leucocytes. In some experiments dead 
bacteria are injected prior to harvest. 
Results 
Normal rat peritoneal macrophages studied by the indirect fluorescent 
antibody technique using anti-rat kidney lysozyme showed a diffuse even 
staining of the cytoplasm with no staining of the nucleus (Plate 3-4). 
In some phagocytic experiments discrete and well circumscribed areas of 
cytoplasmic staining were observed while the cell remained generally 
even staining. 
The appearance of the polymorphonuclear leucocytes is much different 
from that of the macrophages. They characteristically show a pattern of 
discrete highly fluorescent cytoplasmic granules with a lighter, more 
diffuse background(Plate 2). When bacteria are added, a great variety 
of staining patterns are seen including cells with only a few large 
granules, cells with "crescent" formation, and cells with intense diffuse 
staining (Plate 5-10). 
Discussion 
The probable explanation of the differences in the staining patterns 
of the polymorphonuclear leucocytes and the macrophages and in the changes 
that occur during and after phagocytosis is found in the work of Cohn, 
Morse and Hirsh (14-20). They have studied the distribution of hydrolytic 
enzymes within phagocytic cells in both the resting state and after 
phagocytosis. 
They first studied polymorphonuclear leucocytes from acute rabbit 
peritoneal exudates which had been lysed by hypertonic sucrose. The 
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resultant lysate then was separated by differental centrifugation into 
three parts: 400g pellet (nuclear material and cell walls), 8200g pellet 
(larger formed elements of the granulocyte including granules), and 
supernatient (smaller formed elements plus the cytoplasmic contents). 
They then assayed each of the fractions for the activity of acid and 
alkaline phosphatase, ribonuclease, deoxyribonuclease, - -glucuronidase, 
cathepsin, and lysozyme. For all enzymes except lysozyme and cathepsin, 
at least 757, of the activity was found associated with the 8200g pellet 
with the rest being equally distributed between the nuclear and super¬ 
natient fractions (15). For cathepsin and lysozyme the activity of the 
granular fraction was greatly decreased: 257»-nuclear, 457.-granular, 
307,-supernatient. The activity of the nuclear fraction probably is due 
to lysozyme contamination of the nuclear DNA. There probably is no 
lysozyme in the nuclear fraction. 
Hirsh and Cohn then showed that after phagocytosis the polymorphonuclear 
leucocytes became degranulated. This result was easily studied in rabbit 
polymorphs because of the large size of their granules. The proximity 
of a granule to a phagocytic vacuole seemed to determine which ganules 
disappeared because the granules nearest to the vacuoles disappeared 
first (17, 47). The question arose as to whether the granules were 
liberating their contents into the cytoplasm or into the phagocytic 
vacuole. Cohn believed that the contents were released into the vacuoles 
based upon the electron micrographs of Luck (14). The distribution of 
enzymes after phagocytosis and degranulation was studied. It was found 
that in all enzymes studied before there was a change in the distribution 
from being primarily in the granular fraction to being in the supernatient 
fraction (16). In all cases over 607o of the activity was found in the 
supernatient. 
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Cohn and Weiner also subjected macrophages (peritoneal exudates, 
alveolar, and BCG stimulated alveolar) to the same analysis. In terms 
of the total activity of any one enzyme there was no difference in the 
enzyme activity regardless of source except for lysozyme (19). Whereas 
10^ peritoneal exudate macrophages had the activity of 0.4 ug of egg white 
lysozyme, normal alveolar macrophaged had 3.2, and BCG stimulated alveolar 
macrophaged had 9.2. In these studies the centrifugal fractions were a 
500g pellet (nuclei and cell walls), a 15,000g pellet (granular including 
mitochondria), and a supernatient fraction. Again the enzymes, acid 
phosphatase, cathepsin, -glucuronidase, and lysozyme, were studied. 
In all cases greater than 707o of the activity was associated with the 
granular fraction. Moreover, it was shown by density equilibrium studies 
that the granules containing the hydrolytic enzymes, including lysozyme, 
were more dense than mitochondria. After phagocytosis when the assay was 
repeated, there was an increase in the supernatient activity of the enzymes. 
Three hours after phagocytosis 507, of the lysozyme activity was found in 
the supernatient fraction (20). When the macrophages were stained for 
acid phosphatase before phagocytosis, a fine, even, discrete particulate 
pattern was noted throughout the macrophage. After phagocytosis there 
was a loss of particulate cytoplasmic staining with an accumulation of the 
enzyme (acid phosphatase) around the injested particle. This accumulation 
of the enzyme around the injested particle seemed to suggest that the 
degranulation of the granules released their contents into the phagocytic 
vacuole. 
The distribution of lysozyme as shown by fluorescent antibody (44) 
localization agrees well with the enzymatic analysis of Cohn and his co- 
workers. In the polymorphonuclear leucocytes the staining is equally 
distributsd between the granules and the cytoplasm while in the macrophages 
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it is seen diffusely throughout the cytoplasm. When the polymorphs and 
macrophages are stained -with Giesma's stain, the polymorphs show the 
presence of granules while the macrophages do not. However, the staining 
of the macrophages for enzymatic activity (acid phosphatase) shows a fine 
granular pattern. 
The localization of lysozyme in vacuoles in the polymorphonuclear 
leucocytes after phagocytosis is an interesting finding. Originally it 
had been hypothesized that the lysozyme would be found diffusely throughout 
the cytoplasm after degranulation; however, after the results were seen, 
it was observed that, instead of a more diffuse staining pattern, there 
was a more particulate pattern, large areas of staining which seemed to 
coalesce. The question then arose as to whether the areas of the local¬ 
ization of the lysozyme were the phagocytic vacuoles in which the phago- 
cytosed bacteria were and where the apparent destruction of the bacteria 
takes place. In an attempt to show that the areas of increased lysozyme 
concentration were indeed the phagocytic vacuoles, double fluorescent 
antibody studies were undertaken. It was attempted to stain the lysozyme 
(with fluorescein labelled antibody) and the phagocytosed bacteria (with 
rhodamine labelled antibody) hopefully to show that the lysozyme was 
surrounding the bacteria. The results of these experiments were suggestive 
of this state but not definite since the rhodamine that was used gave very 
poor fluorescence. 
When slides of macrophages were stained after having phagocytosed 
bacteria, there were not the marked changes that were seen with the polymorphs; 
however, in some macrophages there was intense localizaed staining in the 
periphery of the cell which would correspond to the localization of the 
acid phosphatase that Cohn showed about injested particles. Thus, it is 
possible that in macrophages also there is a concentration of lysozyme 
within the phagocytic vacuoles. 
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Plate 2 
Mouse blood polj^orphonuclear leucocyte, stained with rabbit 
anti-rat lysozyme serum and fluorescent anti-raooit globulin. 
300 
-jo . ' - L r 
* j.au c j 
Rat peritoneal exudate macrophages, stained, as in Plate 2, 
x 300 
Plate 4 
Louse peritoneal exudate macrophages, stained as in Plate 2. 
x 300 
. 
Plates 5-10 
Polymorphonuclear leucocytes produced by the injection of dead 
E. coll in broth i nt rap eri tone ally in rats, stained as in Plate 2. 
x 300 
Note the apparant increase in size and eventual fusion of the 
lysozyme granules. 
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Plate 7 
Plate 8 

Plate 9 
PIat e 10 
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KIDNEY LYSOZYME ACTIVITY 
History 
Although Fleming's original work showed that the highest concentration 
of lysozyme was found in human tears, other work has shown that the highest 
concentration in most animal species is found in the kidneys (35,63,81). 
This finding is especially surprising since lysozyme is generally associated 
with the reticuloendothelial system and since the kidney is not usually 
accepted as a major component of the system. Increased lysozyme activity 
is found in most instances of increased RES activity: chronic infections 
(88), tumor implants (80), BCG infections, and polymorphonuclear leucocyte 
and macrophage concentration (29, 8). If lysozyme's only action is that 
of attacking the mucopolysaccharide backbone of sensitive bacteria, it is 
surprising that increases are found in the kidney lysozyme concentrations 
in states of RES stimulation. 
Litwack in a series of papers (64, 66, 67) tried to show that the 
increase in kidney lysozyme activity was under the control of a pituitary- 
thyroid axis and was the result of endogenous renal production. He showed 
that in vitro L-thyroxine and tri-iodo-L-tyrosine inhibited lysozyme's 
lytic activity while DL-thyroxine and di-iodo-L-tyrosine had no inhibitory 
effect. Further hypothysectomized rats had higher kidney levels of lysozyme 
than normal controls. He, therefore, felt that the endogenous kidney 
production of lysozyme was under the inhibitory control of the pituitary. 
Perri, however, was able to show that the increase in the kidney 
lysozyme concentration was due to exogenous and not due to endogenous 
production (79, 82). He injected egg white lysozyme intravenously into 
rats, collected their urine for one hour, and then sacrificed them. Sixty 
- ■ V ■ . 
• " 
. ,'j -T 
. 
. 
•_ . . . . . 
’ -' i: • 
-48- 
eight per cent of the injected lysozyme was recovered from the urine. 
There was a great increase in the lysozyme activity of the kidneys; 
however, the activity could be separated into two components by column 
chromatography. These fractions were shown to correspond to egg white 
lysozyme and rat kidney lysozyme, and, thus, 78% of the injected lysozyme 
could be accounted for. Perri, therefore, felt that the increased 
lysozyme concentrations that were found in the kidneys in states of RES 
stimulation were due to the accumulation of lysozyme rather than its 
endogenous production. 
It has been shown many times that in normal urine of either humans 
or rats lysozyme is either absent or present in very small quantities, 
0-2 ug/ml (78, 87, 135). However, in some renal diseases there is marked 
elevation of urinary lysozyme, lysozymuria. Several investigators have 
studied urinary lysozyme levels in attempts to gain data of prognostic 
value for persons suffering from the nephrotic syndrome (10, 136). Their 
conclusions, however, were that there was no correlation between the level 
of proteinuria and the degree of lysozymuria and that the lysozymuria was 
of no prognostic value. 
More recent work has shown that increased urinary lysozyme levels 
are probably more a function of specific tubular damage rather than 
glomerular damage (87). Lysozyme because of its low molecular weight 
is filtered through the glomeruli and then is re-absorbed in the middle 
third of the proximal tubules. In cases of increased glomerular filtration 
no lysozymuria occurs unless the threshold of the tubules for lysozyme 
is exceeded due to increased blood levels or due to tubular damage. The 
production of the nephrotic syndrome experimentally in rats did not 
produce lysozymuria unless there was also treatment with mercuric chloride 
which produces tubular damage. 
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Method 
Normal albino Wistar rats were injected intra- 
peritoneally with 1 ml of incomplete Freund's adjuvant. 
After one month the Freund injected rats and normal 
rats were killed. Their kidneys were frozen, and cryo¬ 
stat sections (3 mu) made. These sections were placed 
on chemically cleaned slides and fixed in 95% ethanol. 
The sections were stained the same day with RB 200 
labelled rabbit anti-rat kidney lysozyme with controls 
of immune and normal ^-globulin. These sections were 
mounted as usual and viewed under darkground fluores¬ 
cent microscopy. 
Discussion 
In the normal kidney discrete regions of staining are seen in specific 
tubules near the glomeruli. These observations agree with those of Oliver 
et al. (75) who showed that the re-absorption of dilute protein solutions 
was accomplished by the formation of "droplets” in the middle third of the 
proximal tubules (118). (Plate 11-16). 
The staining of the kidneys from the Freund's adjuvant stimulated 
rats shows a much more diffuse and much more generalized staining of the 
tubular cells. It has been shown that the lysozyme content of kidneys 
from BCG stimulated rats is twenty times that of normal kidneys (42). 
Oliver showed that, when the level of protein presented to the tubular 
cells is massive, there is not droplet formation with re-absorption, rather 
the re-absorbed protein is found diffusely throughout the tubules. Studies 
with the fluorescent antibody technique indicate that the concepts hold 
for lsyzoyme. (Plate 17-18). 
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Plate 11 
oriual rat kidney, stained, with RB 200 labelled rabbit anti-rat 
lysozyme globulin, 
x 50 
Plate 12 
Normal rat kidney, stained as in Plate 11. 
x 60 
♦ 
•l 
Plate 13 
Normal ret kidney, stained as in Plate 11, 
normal ''-globulin control, 
x 60 
Plate 14 
Normal rat kidney, stained as in Plate 11, 
immune ^-globulin control. 
x 60 

Plate 15 
Normal ret kidney, stained as in Plate 11. 
x 300 
Plate 16 
Normal rat kidney, stained as in Plate 11, 
immune ^globulin control. 
x 300 
. 
Plate 17 
rreund's adjuvant stimulated rat kidney, stained as in Plate ±1. 
x 300 
Plate 18 
Freund's adjuvant stimulated rat kidney, stained as in Plate 11, 
immune Jf-globulin control, 
x 300 
. 
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THE ENZYMATIC ACTION OF LYSOZYME 
Introduction 
Any enzymatic degradation can be divided into two steps: the formation 
of the enzyme-substrate complex and the subsequent chemical transformation 
of the complex (46). The chemical nature of the bond combining the sub¬ 
strate and the enzyme may be either covalent or ionic. The site of the 
binding also may be the site of the enzymatic activity of the enzyme. More 
likely, however, the combining site and the active site are physically 
separated. The combining site assures that the substrate is in the correct 
position so that the active site is in the proper position to react with 
the substrate. 
Freeden (37), by means of methylation of lysozyme, was able to destroy 
its enzymatic activity but not to alter its ability to combine with substrate. 
This suggested that for lysozyme there is separation of combining and 
active sites. Fujio and his co-workers (38, 39, 115) showed even more 
clearly the separation of the combining and active sites. The production 
of antibodies in rabbits to purified egg white lysozyme produced two types 
of neutralizing antibodies. If the anti-egg white lysozyme was absorbed 
by the methyl ester of lysozyme, even with great antigen excess, 20% of 
the neutralizing antibody was not precipitated. All of it was precipitated, 
however, after unaltered egg white lysozyme was added. These results suggest 
there are two antigenic sites on the lysozyme molecule: one is or is close 
to the combining site and the second is or is close to the active site. 
The esterification of egg white lysozyme removes the second antigenic 
site but leaves the first unaltered. From this work it was determined 
that the valence of lysozyme was 5. 
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The efficiency of lysozyme is dependent upon the integrity of both 
its combining site and its active site. Alteration in either of these 
will alter the efficiency. It is not known if at the combining site of 
lysozyme whether the bond between the enzyme and the substrate is ionic 
or covalent. There is some evidence, however, that it is ionic, at least 
in the initial stages. It is natural to assume that there is some ionic 
component due to the high isoelectric point of lysozyme, 10.5-11.0, and, 
therefore, there will be some electrostatic forces between lysozyme and 
all substances with more physological isoelectric points. Moreover, the 
methylation product has even a high isoelectric point and combines even 
more avidly than lysozyme itself with the substrate. The change in 
isoelectric point may be the result of increased negativity, primarily 
in the region of the combining site. The increase in negative charge 
would increase the van der Waal's forces and, thus, the avidity of the 
bond. 
The same situation can be produced by increasing the acidity of the 
substrate. Thus, the rate of the reaction between lysozyme and purified 
M. lysodeikitus cell walls is increased after the cell walls have been 
succinylated(llT)o This could be due to the increased van der Waal's 
forces between the substrate and the enzyme due to an increased charge 
difference. 
It is more difficult to study alterations on the active site as 
opposed to the combining site since any alteration in the site will reduce 
or destroy enzymatic reactivity. The only chemical bond that lysozyme 
attacks is the (3 (1-^H) bond of the AMA-AG disaccharide. Observed differ¬ 
ences in reaction rates with different substrates are determined by the 
steric hindrance that the enzyme must overcome. Thus, lysozyme reacts 
more rapidly with the polysaccharide backbone than it does with the back¬ 
bone with attached peptide chains. 
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Many investigators have studied the effect of chemical alteration of 
the lysozyme molecule on the action of the enzyme. Most of these have 
had no effect or have completely destroyed enzymatic activity; a very few 
have given graded response. One chemical alteration that is of interest 
is the oxidation of the tryptophan residues in lysozyme. There are six 
residues in the lysozyme molecule. They can be sequentially oxidized 
with a continual decrease in enzymatic activity until there is no activity 
when five of the residues have been oxidized (92). Since the valence of 
lysozyme is 5 and since the oxidation of each tryptophan residue reduces 
the activity by 20%, it is possible that each tryptophan residue forms 
part of active site amino acid sequence. 
Experimental 
The specific activity of an enzyme is the ratio between the activities 
of equal weights of the different forms of the enzyme. After purified 
preparations of human kidney lysozyme and rat kidney lysozyme had been 
obtained, their specific activities were determined as compared to purified 
Armour egg white lysozyme. The relative activities were determined by the 
usual method and expressed as ug equivalent egg white lysozyme (EEWL)/ml 
while the protein concentrations were determined by the method of Lowry. 
Table II 
Specific activities of various lysozymes 
Source Relative Activity 
ug EEWL/ml 
Protein Concentration 
mg BSA/ml 
Specific Activity 
Egg White 100 24 1.00 
Human Kidney I 62 8 1.85 
Human Kidney II 89 12.5 1.71 
Rat Kidney 75 20 .90 
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Discussion 
The results are surprising since Jolles has reported (51) that human 
milk lysozyme is less active than egg white lysozyme. He showed that 
lysozyme preparations in decreasing order of specific activities were 
obtained from duck's eggs, hen eggs and human milk. This also is the 
order of the degree of their basic amino acid content. The fact that 
an increased basic amino acid content leads to a more active form of the 
enzyme is not surprising in view of the previous discussion. 
The order of specific activity, human, egg, rat, agrees well, however, 
with the information that can be obtained from their elution from a CMC 
column by a pH-molar gradient (Figure 8). The egg white and rat kidney 
lysozymes are eluted over the same tube spread while the human kidney 
lysozyme is eluted at a higher pH and molarity, thus, demonstrating its 
greated basicity. 
Attempts to confirm this order of specific activity by electrophoresis 
in acrylamide produced the order, egg, rat, human (Plate 19). In electro¬ 
phoresis the separation is a function of tha total molecular charge differ¬ 
ences, and the separation on chromatographic columns is a function of the 
surface charge differences. It is not surprising that only the column 
chromatographic data agrees with the specific activities since the differ¬ 
ences in activities are probably due to differences in surface charge 
rather than to differences in total charge. As was discussed, it 
appears to be the surface charge difference between the enzyme and the 
substrate which determines the rate of the reaction. 
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Plate 19 
Electrophoresis of different lysozymes 
5/3 acrylamide, barbitone buffer, pH 8.5, 18 hrs. 
Top: Human Kidney Lysozyme 
Middle: Purified Ess White Lysozyme 
Bott orn: Rat Ki dne3^ Ly so zym e 
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ISOENZYMES 
Introduction 
Markert and Moiler (71) defined isoenzymes as the different molecular 
forms in which proteins may exist with the same enzymatic specificity. In 
their work with lactic acid dehydrogenase they showed that five electro- 
phoretically distinct forms existed and that the ratio of these forms 
varied with the source of the enzyme, even within the same species. The 
variation in the ratio of the different isoenzymes has lent itself to 
becoming a diagnostic tool. Whereas correlation of total serum LDH values 
with specific pathological changes is difficult, the correlation with 
specific isoenzyme changes is high. In heart miscle the electrophoretically 
faster components predominate while in liver and sketal muscle the slower 
components predominate. Thus, changes in the levels of the different 
isoenzymes of LDH is suggestive evidence of the site of disease (132). 
It has been shown by column chromatography that egg white lysozyme 
can be separated into two enzymatically active components (1,2) and that 
there is an interconversion between these two components (124, 125). 
Attempts at their electrophoretic separation have not been definitive. 
One group reported the occasional presence of a second band (5, 126) while 
another reported the presence of one prinicpal peak with shoulders which 
they interpreted as hetrogenicity (89). 
In the attempts to determine the relative electrophoretic mobilities 
of lysozyme from different sources, the separation of the isoenzymes of 
egg white lysozyme and the partial separation of the isoenzymes of human 
kidney lysozyme was achieved. 
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Method 
A 5% solution of acrylamide in buffer was made up 
(Cyanogum 41, British Drug House) to which was added 0.13 
ml 2-dimethyl-amino-ethyl cyanide per 100 ml of solution 
per 1% acrylamide. Then 0.13 ml of freshly prepared ammon¬ 
ium persulfate was added per 100 ml of solution per 1% acryla¬ 
mide (93). The solution was poured into the mold and sealed. 
The rate of gelling could be hastened by placing the mold in 
an incubator at 37°C. A mold, 25 x 10 x 1 cm, was used; this 
size allowed the study of four samples at once. In some 
experiments the gel was made up with 8M urea in order to 
achieve better separation of the isoenzymes(116). 
The power source used was a VOKAM power pack (Shandon 
Scientific Co., Ltd., London). The buffer system was discon¬ 
tinuous with the cathode bath at a high molarily so as to 
reverse the normal electro-osmotic flow. The protein solution 
under study were in the range, 5-10 mg/ml. They were applied 
to Whatman's #1 filter paper and placed in slits or were placed 
directly into slots in the gel. A constant amperage of 2.5 
mA/cm was used (^150 V)., and the duration of the runs was 
between 12 and 25 hours. At the completion of a run the gel 
was fixed for 15 minutes in 10% TCA and then stained in a 
concentrated solution of Light Green stain. The gel was then 
washed in a 5% acetic acid-water until clear. 
Discussion 
There was separation of both Amour crude egg white and Armour purified 
egg white lysozymes into two electrophoretically distinct components. There 
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also was partial separation of human kidney lysozyme into two components 
(Plate 20). These results agree with the results from the column chroma¬ 
tography of egg white lysozyme (124, 125). The separation of freshly 
purified egg white lysozyme on IRC-50 yielded two peaks whose ratio was 
95-5. Chromatography of the same sample after one year gave a ratio of 
60-40 leading the authors to believe that there was an interconversion 
between the two forms. Densometric analysis of the separation products 
of the Armour purified egg white lysozyme in acrylamide showed a ratio 
of 88-12 while the Armour crude egg white lysozyme showed a ratio of 
70-30. These values agree well with the column data. The question 
arises as to whether the purification process selectively removes one 
component or whether it causes an interconversion of the forms which 
reverts if the lysozyme is allowed to stand. 
Litwack (68) noted the presence of two peaks of activity in his 
purification of human kidney lysozyme on IRC-50 but he was unable to 
obtain complete separation. The availability of newer techniques now 
should make possible the electrophoretic separation of human kidney lyso¬ 
zyme into its two components. In these studies no separation of rat 
kidney lysozyme occured although Litwack (65) has reported the presence 
of three peaks by column chromatography. 
Whereas other enzymes besides LDH are being subjected to diagnostic 
isoenzyme separation, i.e. L-glutamate dehydrogenase (129), it is possible 
that the determination of the ratios of the isoenzymes of lysozyme from 
different human tissues might become a convenient diagnostic aid. 
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SUMMARY 
A new method has been established for the extraction of lysozyme 
from human kidney. During the extraction procedure a 3% fold increase 
in activity was achieved by the removal of an inhibitor, possible spermine. 
The localization of lysozyme in rat and mouse phagocytic cells before 
and after the phagocytosis of dead bacteria has been studied be means of 
the indirect fluorescent antibody technique. Normal polymorphonuclear 
leucocytes showed locatization of the lysozyme in cytoplasmic granules 
with a faint, diffuse cytoplasmic staining while in the macrophages the 
lysozyme was diffusely distributed throughout the cytoplasm. After 
phagocytosis the polymorphonuclear leucocytes showed a variable pattern 
which included larger granules, crescent formation, and generalized 
cytoplasmic staining. In contrast, in the macrophages there was little 
visible change except for occasional cytoplasmic droplet formation showing 
localized concentration of lysozyme. 
The localization of lysozyme by the fluorescent technique agrees wiith 
the enzymatic assay for lysozyme that have been done on these cells before 
and after phagocytosis by other authors. Several questions still remain 
unanswered. It still has not been shown that the concentration of the 
lysozyme that occurs after phagocytosis is in the phagocytic vacuoles. 
The proof of this concentration could be obtained either through double 
fluorescent antibody studies or with ferritin labelled anti-lysozyme and 
electron microscopy. 
The reason why the anti-lysozyme was originally prepared was for the 
further study of the role of lysozyme in the intracellular destruction of 
bacteria. These studies could now be continued using a double antibody 
against both the bacteria under study and lysozyme hoping to show a differ- 
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ence in the killing curve between those bacteria protected with the anti- 
lysozyme and those unprotected. The difference between the killing curves 
would be a measure of the role of lysozyme in the destruction of that 
species of bacteria. These studies should cover a wide spectrum of bacteria 
to see what the role of lysozyme is in resistance to each of them. 
In normal rat kidneys it was shown that lysozyme is found in droplets 
in the proximal tubules by the direct fluorescent antibody technqiue while 
in kidneys from Freund's adjuvant stimulated rats there was diffuse staining 
of all the tubular cells. The fate of lysozyme in the kidney is uncertain; 
is it enzymatically degraded and the resultant amino acids and peptides 
released into the blood stream or is it released as unaltered lysozyme 
that can be re-utilized by phagocytic cells without alteration. Answers 
to these questions would have applicability to the whole field of protein 
metabolism. Answers could be derived by I labelling of purified rat 
lysozyme and injecting it into rats. The majority of it would be re-absorbed 
by the kidney tubules, and then its ultimate distribution could be deter- 
mined which would give evidence as to its metabolism. If the IIJ was 
found only in phagocytic cells, then it is probably that the lysozyme is 
re-utilized in an unaltered state, but, if the label was found diffusely 
throughout the body, it wjuld show that the lysozyme had undergone degradation. 
The specific activities of a series of lysozymes from different sources 
was established: human kidney, 1.75, egg white, 1.00, and rat kidney, 0.90. 
The electrophoretic separation in acrylamide of the isoenzymes of egg 
white lysozyme was achieved as well as the partial separation of the iso¬ 
enzymes of human kidney lysozyme. There are two electrophoretically separatable 
compenents to both enzymes. Further work should be carried out on the human 
lysozyme to see if there is any organ specific pattern of ratio of the 
isoenzymes that might be a diagnostic aid in clinical medicine. 
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